Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Bioxcel Therapeutics, Inc
Biopharmaceutical company developing transformative medicines in neuroscience utilizing artificial intelligence
51 to 200 staff
Boca Biolistics, Llc
We are a one-of-a-kind resource built for the future of life science research. BocaBio is a hybrid CRO serving the pharmaceutical, biotech, and IVD industries ISO-certified Biobanx biospecimen inventory ACRP and CCRA-certified clinical research services CLIA-certified and CAP-accredited reference laboratory services We help pharmaceutical and IVD research companies develop tomorrow’s therapies Our biobank, CRO, and reference lab services enable: Pharmaceutical companies to develop novel therapeutic drugs. IVD companies to develop innovative diagnostic technologies Biotech companies to conduct critical research.
11 to 50 staff
Cellworks
Cellworks Group, Inc. is a leader in Precision Drug Development and Personalized Therapy Biosimulation. The Cellworks Platform predicts therapy response for individual patients and patient cohorts using a breakthrough Computational Biology Model (CBM) and biosimulation technology. Backed by Artiman Ventures, Bering Capital, Sequoia Capital, UnitedHealth Group and Agilent Ventures, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers and software technologists working toward a common goal – attacking serious diseases to improve the lives of patients.
51 to 200 staff
Central Life Sciences
Central Life Sciences is dedicated to creating healthier environments by offering trusted consumer and professionally-applied solutions to control nuisance and disease-carrying insects and support human and animal health. For more than 35 years, the professionals at Central Life Sciences, a Central Garden & Pet Company, have been dedicated to improving the health, well-being and protection of animals, plants and stored grains through a wide variety of effective products.
51 to 200 staff
Elegen
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges. Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.
51 to 200 staff
Greenlight Biosciences
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of nature to develop and commercialize effective, easy-to-use, and environmentally friendly crop protection for farmers.
51 to 200 staff
Hamilton Company
Hamilton Company is a global enterprise with headquarters in Reno, Nevada; Franklin, Massachusetts; and Bonaduz, Switzerland and subsidiary offices throughout the world. We are an industry leader in the design and manufacture of liquid handling, process analytics, robotics and automated storage solutions. For more than 60 years, Hamilton has been meeting customer needs with a combination of quality materials and skilled workmanship that ensures the highest level of performance. Hamilton’s continued commitment to precision and quality has earned the company global ISO 9001 Certification. Founded on the technology of analytical microliter and gastight syringes, Hamilton has a broad offering of laboratory products including manual and semi-automated precision fluid measuring instruments, chromatography products, process sensors, laboratory electrodes, pipettes and more. Top innovations from these lines include Arc™ pH, DO and conductivity intelligent sensors, the BioLevitator™ 3D cell culture system, Microlab® 600 diluters/dispensers and the Microlab 300 guided pipetting system. The leader in liquid handling technology, Hamilton Robotics is recognized for advancing life science and biotechnology industries with products that offer reliability, performance and flexibility. Hamilton is the industry leader in design and manufacturing, with patented technologies such as Compression-induced O-Ring Expansion CO-RE™, Total Aspiration and Dispensing Monitoring TADM™ and Anti-Droplet Control ADC™. Hamilton’s platforms include VANTAGE Liquid Handling System™, Microlab STAR™ and Microlab NIMBUS®. Hamilton Storage offers comprehensive ultra-low temperature automated sample management systems for microtube and microplate storage. Hamilton’s line of biobanking and compound storage solutions and consumables is designed for a broad array of life science processes. Products include BiOS™, SAM™ and ASM™, designed for sample integrity, flexibility and reliability.
501 to 1000 staff
Human Longevity, Inc
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
51 to 200 staff
Immuneering Corporation
Immuneering is a clinical-stage oncology company focused on keeping cancer patients alive. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors. Immuneering’s lead product candidate, atebimetinib (IMM-1-104), is an oral, once-daily Deep Cyclic Inhibitor of MEK designed to improve durability and tolerability, and expand indications to include MAPK pathway-driven tumors such as most pancreatic cancers. Atebimetinib is currently in a Phase 2a trial in patients with advanced solid tumors including pancreatic cancer. The Company’s development pipeline also includes early-stage programs. For more information, please visit
11 to 50 staff
Immunomic Therapeutics, Inc
Immunomic Therapeutics, Inc.(ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.
11 to 50 staff
Immy
Bringing Diagnostics closer to the patient. IMMY is a global leader in fungal and infectious disease diagnostics. Headquartered in Norman, Oklahoma since 1979, we design, manufacture, and distribute affordable and reliable diagnostic tests that bring diagnostics closer to the patient and improve clinical outcomes around the world. IMMY is committed to addressing the global challenges of delayed, inaccurate, and inaccessible fungal diagnostics by delivering innovative, high-quality solutions that ensure the right information reaches the right people at the right time. We empower healthcare providers to make informed treatment decisions that improve outcomes for patients worldwide. Through this commitment, we reduce diagnostic gaps and enhance the speed and precision of fungal disease detection, keeping the patient at the center of everything we do. With a legacy rooted in mycology and a mission to save lives, IMMY’s rapid diagnostic tools, including our flagship CrAg® LFA, help detect life-threatening infections in immunocompromised patients and elevate the standard of care in over 100 countries. Our values, compassion, innovation, simplicity, integrity, customer focus, and teamwork, drive every decision we make. Recognized as a Top Workplace and Biotech Innovator of the Year, IMMY is also one of Oklahoma’s fastest-growing life science companies. Join us in shaping the future of global health.
51 to 200 staff
Inscopix, Inc
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia. Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: Privacy Policy: https://goto.bruker.com/LI-Bruker-PrivacyPolicy Imprint: Bruker Corporation 40 Manning Road Billerica, MA 01821, USA
51 to 200 staff
Intrexon Corporation
Through the engineering of biology, Intrexon is helping to address some of the world’s most pressing challenges and is working with industry and government leaders to realize a better, healthier planet. Today our platform is delivering new therapies in health, supplying unique solutions to address global energy demand, developing unparalleled features and productivity advancements in food, creating innovative applications for consumers, and helping to restore and protect the environment. Intrexon and our collaborators are building solutions to challenging issues across fields as diverse as medicine, fuel, agriculture, nutrition, personal care, chemicals, and manufacturing, forging a sustainable path forward for current and future generations. We call our approach Better DNA® and invite you to discover more at or follow us on Twitter at @Intrexon, on Facebook and LinkedIn.(NASDAQ:$XON)
501 to 1000 staff
Krystal Biotech, Inc
A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs.
201 to 500 staff
Leinco Technologies
Consultative Partner Over 30 years’ experience closely collaborating with companies to ensure high quality, reproducible products that drive scientific discovery. Custom CDMO Services From antibody scale-up and purification to advanced conjugation and assay development, our tailored services streamline your workflow and accelerate research. Wide-Ranging Applications Our products are optimized for diverse applications—including spatial biology, flow cytometry, in vivo studies, and in vitro assays—to empower researchers to uncover critical biological interactions. Advanced Production Techniques Our proprietary processes yield the purest monoclonal, recombinant, and polyclonal antibodies and proteins available, ensuring high-purity reagents that drive consistent, reproducible results. Quality & Standards Quality is non-negotiable -we strictly adhere to ISO 9001:2015 and ISO 13485:2016 standards, ensuring that every antibody and protein we produce meets rigorous performance and reliability benchmarks.
51 to 200 staff
Maia Biotechnology, Inc
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials. MAIA’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.
1 to 10 staff
Metabolon, Inc
Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions. Metabolon's unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules. Our proprietary Precision Metabolomics™ platform, combined with the world's most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. Founded in and based in Research Triangle Park, North Carolina, Metabolon has conducted more than independent and collaborative studies, resulting in publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit
201 to 500 staff
Noble Life Sciences Inc
Noble Life Sciences is a contract research organization (CRO) that provides a full continuum of preclinical drug, vaccine and medical device development services, from initial product discovery to GLP-compliant studies. Our services are designed to help you advance from concept to clinic faster and more efficiently. Noble's state-of-the-art facilities are located in Sykesville, MD in the BioHealth Capital Region. We offer integrated in vitro and in vivo services, including cellular and animal disease model development and experimental design, efficacy, toxicity, biodistribution and product release studies in both small and large animals. Managed by industry experts with years of experience in animal care, Noble's vivarium services group is ready to support your in vivo R&D: we provide custom housing, husbandry, and breeding; facility and program management; and high-level implementation of preclinical drug development services. Noble also offers custom antibody production services as well as tissue and animal sourcing. With an emphasis on quality, our proof-of- concept studies, early safety assessments and other pre-IND services are sure to provide a strong scientific foundation for your preclinical decisions. Noble’s key advantages are our deep expertise and the years of experience of our scientific team, who bring their insights to optimize and expedite our customers’ preclinical studies. With our quality control and expertise in cell- & animal-based models, you can trust Noble scientists to help lead and support your development programs through each phase of the preclinical process.
11 to 50 staff
Nucleus Biologics
Nucleus Biologics is a San Diego based biotechnology company and a global provider of media and supplements for the cell and gene therapy space. Their mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. Nucleus Biologics delivers innovative, transparent and cGMP products and services with the goal of disrupting the market and eliminating antiquated practices and products. Ultimately, Nucleus Biologics strives to create a new paradigm that serves both scientists and clinicians, while reducing the environmental footprint of cell culture.
51 to 200 staff
Nuo Therapeutics, Inc
Nuo Therapeutics, Inc. is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure injuries.
11 to 50 staff
Nuritas
Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions.
51 to 200 staff
Pillar Biosciences Incorporated
Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar’s NGS testing solutions are powered by its proprietary SLIMamp® and PiVAT® technologies, helping to localize the testing process, reduce diagnostic costs and improve access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The company has more than 20 NGS testing kits available in IVD or RUO formats, with multiple panels in various stages of development. Pillar Biosciences has operations in Natick, MA.
51 to 200 staff
Procell Therapies
ProCell Therapies is a leading-edge medical device and biotech/stem cell company in the $6B burdening cosmetic, spa and dermatology space. It has invented a superior device, application method and demonstrated results in generating skin vitality and healing skin injuries. Founded by a Board Certified, Academy of Dermatology MD; top-tier academic and clinical board of advisors.
11 to 50 staff
Prometheus Laboratories Inc
At Prometheus Laboratories Inc, we enable unique health solutions with novel diagnostics. As a leader of precision healthcare in gastroenterology, we develop and bring to market diagnostic tests that help physicians provide the highest level of patient care. Our commitment to innovation positions us for future growth and lays the foundation for expansion into new areas. Every day our people and products earn the trust of patients and their families.
51 to 200 staff
Scantibodies Laboratory, Inc
In vitro diagnostic company, specializing in the production of antibodies, controls, blockers including HBR- Clean Rooms - Filling - Finishing - Packaging - Sub-Assembly - Inventory Space - Kit Manufacturing - Lyophilization - Antibody Production - Medical Device Manufacturing
501 to 1000 staff
Scholar Rock
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/
51 to 200 staff
Science Care, Inc
Science Care sets the standard of excellence in the donation and responsible use of human tissue for medical research, surgical training, and professional education. We are the first organization accredited by both the American Association of Tissue Banks (AATB) and the Accreditation Council for Continuing Medical Education (ACCME)—recognitions that reflect our commitment to quality, safety, and respect for donors, researchers, and educators. Since our founding in we have trained over surgeons and physicians at our state-of-the-art medical training facilities. Headquartered in Arizona, we also operate facilities in California, Colorado, Florida, Pennsylvania, Illinois, and Texas. Science Care donors have contributed to groundbreaking advances in medical devices and treatments, helping make care safer and more effective for patients. Through whole-body donation, we honor donors’ and families’ wishes to leave a lasting legacy. Safety: Every donor undergoes a thorough evaluation, including a complete medical and social history and comprehensive blood testing, ensuring suitability and safety. Our facilities meet or exceed OSHA standards and follow rigorous policies and procedures to protect donors, staff, and the public. Consistency: For more than 20 years, Science Care has connected donors with medical researchers and educators, advocating for responsible, non-transplant tissue banking. Staffing: Our team includes licensed medical directors and Certified Tissue Bank Specialists. All employees undergo detailed background checks and specialized training. Availability: We provide dedicated, 24/7 customer support. Our team responds promptly to inquiries via our toll-free line at 800.417.3747.
51 to 200 staff
Seed Health
Seed Health is a microbiome science company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough discoveries in microbial sciences across a pipeline of novel therapeutics, consumer health innovations and environmental solutions. All consumer innovations in probiotics are commercialized under Seed®.
51 to 200 staff
Select Sires Inc
Based in Plain City, Ohio, Select Sires Inc. is committed to enhancing the productivity and profitability of dairy and beef producers. Highly fertile semen and genetic consultation are provided by three farmer-owned and -controlled cooperatives domestically, while World Wide Sires, Ltd. delivers international service. As the industry leader, Select Sires Inc. supplies farmers and ranchers with the world's best genetics, services and programs. We Value: • Responsiveness to customer needs • Highly trained, professional personnel • High quality at a fair price • Industry leadership • Product and service innovation • Commitment to research • Good stewardship of assets • Continuous improvement • Integrity in everything we do
201 to 500 staff
Seqwell
seqWell creates scalable genomics technologies that simplify library preparation workflows and help scientists to unlock transformative discoveries with sequencing. seqWell technology is focused on a novel, next-generation transposase, TnX™, to drive the scalability and high-performance needs of tagmentation and advance NGS. seqWell offers a range of library prep products and fragmentation workflows that allow customers to quickly and easily scale their short- and long-read sequencing initiatives.
11 to 50 staff
Soligenix, Inc
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics business segment is developing and commercializing HyBryte™ (SGX301 or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). With a successful Phase 3 study completed, regulatory approval and commercialization for this product is being advanced initially in the U.S. Development programs in this business segment also include expansion of synthetic hypericin (SGX302) into psoriasis, our first-in-class innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, and proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention / treatment of gastrointestinal (GI) disorders characterized by severe inflammation, including pediatric Crohn's disease (SGX203). Our Public Health Solutions business segment includes active development programs for RiVax®, our ricin toxin vaccine candidate, and vaccine programs targeting both filoviruses (such as Marburg and Ebola) and coronaviruses (COVID-19; CiVax™). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax®. We are also developing SGX943, our therapeutic candidate for antibiotic resistant and emerging infectious disease. To date, this business segment has been supported with government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID), the Biomedical Advanced Research and Development Authority (BARDA), and the Defense Threat Reduction Agency (DTRA).
11 to 50 staff
T2 Biosystems
T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at
51 to 200 staff
Tasso, Inc
Tasso is a fast-growing Seattle-based startup focused on delivering at-home diagnostic testing to those who need it most. We are growing our footprint with leading health systems, clinical research organizations, academic medical centers, and more who are looking to deliver clinical-grade, convenient diagnostic tests to their patients. Tasso was originally founded to find a better way to collect blood instead of a painful fingerstick or time-consuming venous draw. Since then, our products have been used in pharmaceutical clinical trials, by Olympians as part of a new virtual anti-doping program, and broadly by hospital systems across the US.
51 to 200 staff
Teledyne Photometrics
Teledyne Photometrics is the established leader in the global scientific community for high performance CMOS, CCD and EMCCD cameras that support demanding, quantitative bio-research. The original architect of both the first scientific-grade EMCCD and the first back-illuminated sCMOS camera, we continue to lead the industry with the new Kinetix sCMOS which redefines scientific CMOS performance capability with an unmatched combination of speed, sensitivity, and field of view. Teledyne Photometrics also offers a comprehensive OEM program that enables customers to integrate cameras in a wide variety of configurations, from complete, ready-to-run camera systems to component level, single-board cameras. A dedicated team ensures rapid integration with software, optical, electrical and mechanical elements. Founded in 1978, Teledyne Photometrics is headquartered in Tucson, Arizona in the US and is a registered ISO 9001:2015 and ISO 13485:2016 company. Teledyne Photometrics has been a part of the Teledyne Imaging Group since 2019. See Photometrics’ Rich History of Key Achievements at
51 to 200 staff
Usa Scientific
USA Scientific manufactures and distributes high-quality laboratory plastics, equipment, and accessories. We serve life science and other research communities involved in basic research, drug discovery, development, diagnostics, food science, forensics, and other areas of laboratory science. USA Scientific has been a trusted laboratory partner since 1982. Our nationwide sales force has extensive product knowledge, and our in-house customer support team is committed to fast and friendly service. Three US distribution centers assure rapid, on-time delivery. Our products include: TipOne® universal, filter, and low retention pipette tips; ErgoOne® pipettes; CytoOne® cell culture ware; standard and real-time PCR tubes, plates, and film; centrifuge, culture, and other tubes; bar-coded tubes and sealing options; assay plates and sealing film; freezer racks; storage boxes and labels; gloves; centrifuges and bench top equipment; laboratory organizers; and many other items. We are also a distributor for Eppendorf, Greiner Bio-One, Micronic, BioMicroLab, Diversified Biotech, Scientific Industries, and other fine laboratory suppliers.
51 to 200 staff
Vector Laboratories, Inc
Founded in 1976, Vector Laboratories has been a trusted partner to the global scientific community for nearly five decades. Starting with immunohistochemistry, we’ve grown into a leader in labeling, detection and conjugating technologies for fields like neuroscience, cancer research, and infectious disease. Through strategic acquisitions, including Click Chemistry Tools, Fluoroprobes, Quanta Biodesign, and our merger with Absolute Biotech, we’ve significantly broadened our product portfolio to offer even more high-performance solutions for cutting-edge research. Headquartered in Newark, California, we have labs and offices across the U.S, in the UK, and in Europe, supporting researchers worldwide. At Vector Laboratories, we’re more than just a supplier – we’re your partner in scientific excellence.
201 to 500 staff
2seventy Bio
2seventy bio is now part of Bristol Myers Squibb. Follow our progress in #CARTcelltherapy @Bristol Myers Squibb or
51 to 200 staff
4c Medical Technologies, Inc
4C Medical Technologies, Inc. is a medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR). We are the first transcatheter MR therapy that directly addresses mitral regurgitation without replacing the native mitral valve, thus preserving the native mitral annulus and left ventricle. The device is positioned supra annular to the leaking native mitral valve to stop the leak from entering the left atrium. Its atrial only fixation ensures minimal disruption to critical cardiac structures within the left ventricle including the chordae tendineae and the left ventricular outflow tract. Our initial focus is to develop a novel therapy for mitral regurgitation (MR), and subsequently for tricuspid regurgitation (TR).
11 to 50 staff
Acrotech Biopharma Inc
Founded in 2018, Acrotech Biopharma Inc was formed as a global platform to commercialize innovative proprietary medications. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders. Acrotech aspires to be a patient focused, research based organization that strives to launch treatments which are accessible to patients that need them.
51 to 200 staff
Ads Biotec Inc
We provide Automated Instruments and Bioconsumables to enhance productivity in Cytogenetics, Molecular Genetics, and Pathology. With our expertise in RNA purification, and Custom Manufacturing, we accelerate innovation in Precision Medicine, Diagnostics, and Therapeutics ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories. Our technology and services enable our customers to increase productivity and throughput while maintaining a high degree of quality and consistency. With the acquisition of the Genetic Assays and Platforms (GAP) Division from Transgenomic, ADS Biotec Inc. has a truly global presence with development, sales and support operations on three continents and users in over 30 countries. Our team, having over 20 years of experience in this industry, is recognized by our customers for our advanced instrumentation, superior customer service, scientific application support, and a very knowledgeable sales force. With a company-wide commitment to quality and value, we serve professionals and laboratories performing diagnostic analysis in the areas of Cytogenetics, Pathology, and Molecular Genetic Analysis.
11 to 50 staff
Agdia Inc
In 1976 Alister Voller, Mike Clark, and associates reported the successful and sensitive detection of plant viruses by ELISA. Two years earlier, Voller, Engvall, Bidwell and Huldt developed the microwell ELISA plate. This technology arrived just in time to test and select plants grown by tissue culture and to assist clean plant programs using one-way pass-through propagation methods. The rapid exploration and acceptance of ELISA created an immediate need for optimized, validated tests, for kits, for quality controlled antibodies, enzyme conjugates and accessories. Agdia, Inc. was formed to meet this need. Agdia’s first tests were developed for common potato pathogens, i.e, the viruses, PVX, PVY, PLRV, PVS, PVM, PVA and the bacteria, ringrot [Cms] and blackleg [Eca]. Next, a Testing Service was developed to help those who needed testing results but did not want to perform the tests themselves. The products and services were an instant hit. Agdia grew quickly as its products and services became known worldwide. In rapid succession many tests were developed for fruit, ornamental and field crops. And, significant advances were made in test formats and test type, including, the PathoScreen® test format, the potyvirus group test, membrane assays for viroids, nested PCR for phytoplasma, PCR virus group tests and ImmunoStrips®. All of this was possible only because a worldwide community of scientists and customers provided technology, biomaterials, plant samples and constant encouragement. Agdia’s continuing focus on developing and performing tests for plant pathogens and dedication to confidential customer service and support have earned a special trust and place in the worldwide agricultural community. We value and treasure this trust. And, with each day, we dedicate ourselves anew to providing you with products and service that enable you to grow healthy crops with confidence.
51 to 200 staff
Agriplex Genomics
AgriPlex Genomics was formed in 2014 with the goal of creating a platform for targeted sequencing and genotyping in very large populations. We specialize in focused, simultaneous analysis of limited numbers of loci (few to several hundreds) in any number of DNA samples in support of animal and plant breeders. The multiplexed Next-Gen PlexSeq™ platform will greatly improve throughput and efficiency while significantly reducing costs. AgriPlex Genomics partners with plant and animal breeders and researchers to identify desirable traits, leading to healthier and more productive crops and livestock.
51 to 200 staff
Aliri Bioanalysis
Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.
51 to 200 staff
Altis Biosystems
Altis’ mission is to provide scientific innovation, through collaborative relationships, by helping companies develop safer and more effective therapies to treat patients suffering from human disease. We support life science researchers by providing expertise and unique in vitro platforms to further their research and increase their understanding of human biology, while reducing the need for animal testing. Altis Biosystems has pioneered the creation of Repligut® Systems, a collection of in vitro models derived from stem cells and designed specifically for pre-clinical drug discovery. These innovative systems overcome the constraints of conventional cell lines and animal models, providing a highly accurate representation of human intestinal physiology. Our flagship RepliGut® Planar models advance novel pharmaceuticals by harnessing the potential of human donor intestinal stem cells. These cells undergo a process of sequential proliferation and differentiation, ultimately transforming into the essential cell types found in the human gastrointestinal epithelium for use in drug discovery and development. Our RepliGut® Models, which accurately replicate the complex cellular lifecycle of the intestinal crypt, provide an exceptional platform for numerous applications. Derived from various regions of the intestine, they allow for compound screening, disease modeling, drug disposition analysis, toxicity assessments, efficacy studies, and fundamental research investigations. With their human-derived physiologically-relevant capabilities, our models have the power to vastly reduce the dependence on animal studies, in line with the transforming landscape of pre-clinical drug discovery.
11 to 50 staff
Analytical Resource Laboratories, Llc
Analytical Resource Labs (ARL) is an ISO/IEC 17025:2017 accredited, DEA-licensed, and FDA-registered lab that offers microbiological and chemical services, including HPLC, GC, ICP, and stabilities, in the foods, cosmetics, dietary supplements, and pharmaceutical industries since We are the preferred testing lab for the American Kratom Association, and have extensive experience in Cannabinoid and THC testing. ARL is headquartered in Lehi, Utah, and has locations in Washington, UT; Tempe, AZ; and St. Petersburg, FL.
51 to 200 staff
Ascidian Therapeutics
Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resulting in full-length, functional proteins at the right levels, in the right cells, at the right time. With active discovery and preclinical programs in ophthalmology, neurological and neuromuscular disorders, and other rare diseases, Ascidian is opening new therapeutic possibilities for patients in need of breakthroughs. For more information, visit
11 to 50 staff
Asuragen, A Bio-Techne Brand
Asuragen, a Bio-Techne brand, is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. Bio-Techne a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.
51 to 200 staff
Biologos
A Trusted Biologics Partner Since 1976 Biologos is a full-service manufacturer of standard and custom cell culture media, buffers, reagents, and sera specializing in quick turn product formulation, manufacturing and distribution. As our customers pursue the global advancement of health and wellness, we built our company on a foundation of continuous improvement of our processes, equipment and expertise. Our Mission To exceed customer expectations through the production of superior standard and custom products, driven by our commitment to customer satisfaction, continuous innovation, and excellence in manufacturing.
11 to 50 staff
